TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells. (7th November 2013) - Lu, Hailing; Yang, Yi; Groh, Veronika; Spies, Thomas; Dietsch, Gregory; Matthews, Maura; Disis, Mary L; Hershberg, Robert